LRRK2 and Parkinson disease: The absence of LB pathology is observed in G2019S LRRK2-PD carriers, as well as in carriers of the highly penetrant LRRK2 mutations such as R1441C/G, Y1699C, or I2020T (Schneider and Alcalay, 2017).